EXTRACORPOREAL PHOTOPHERESIS IN A RAT MODEL OF PULMONARY FIBROSIS

REFERENCES

• Oliven A, Shechter Y. Extracorporeal photopheresis: a review. Blood Rev 2001; 15: 103–108
   PubMed Web of Science ®Google Scholar
• Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Transfus Apher Sci 2003; 29: 61–70
   PubMed Web of Science ®Google Scholar
• Bladon J, Taylor P C. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes. Photodermatol Photoimmunol Photomed 2005; 21: 293–302
   PubMed Web of Science ®Google Scholar
• Bladon J, Taylor P C. Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 2006; 43: 85–94
   PubMed Web of Science ®Google Scholar
• Fimiani M, Di Renzo M, Rubegni P. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Br J Dermatol. 2004; 150: 1055–1060
   PubMed Web of Science ®Google Scholar
• Maeda A, Schwarz A, Kernbeck K, Gross N, Aragane Y, Peritt D, Schwarz T. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol. 2005; 174: 5968–5976
   PubMed Web of Science ®Google Scholar
• Lamioni A, Parisi F, Isacchi G, Giorda E, Di Cesare S, Landolfo A, Cenci F, Bottazzo G F, Carsetti R. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005; 79: 846–850
   PubMed Web of Science ®Google Scholar
• Biagi E, Di Basio I, Leoni V, Gaipa G, Rossi V, Bugarin C, Renoldi G, Parma M, Balduzzi A, Perseghin P, Biondi A. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CG25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007; 84: 31–39
   PubMed Web of Science ®Google Scholar
• Meloni F, Cascina A, Miserere S, Perotti C, Vitulo P, Fietta A M. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007; 39: 213–217
   PubMed Web of Science ®Google Scholar
• Strieter R M. Pathogenesis and natural history of usual interstitial pneumonia. The whole story or the last chapter of a long novel. Chest. 2005; 128: 526S–532S
   PubMed Web of Science ®Google Scholar
• Gross T J, Hunninghake G W. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345: 517–525
   PubMed Web of Science ®Google Scholar
• Parra E R, Kairalla R A, Ribeiro de Carvalho C R, Eher E, Capelozzi V L. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration 2007; 74: 159–169
   PubMed Web of Science ®Google Scholar
• Chua F, Gauldie J, Laurent G J. Pulmonary fibrosis. Searching for model answers. Am J Respir Cell Mol Biol 2005; 33: 9–13
   PubMed Web of Science ®Google Scholar
• Wallace W A, Ramage E A, Lamb D, Howie S E. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 1995; 101: 436–441
   PubMed Web of Science ®Google Scholar
• Keane M P, Belperio J A, Burdick M D, Strieter R M. IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2001; 281: L92–L97
   PubMed Web of Science ®Google Scholar
• Belperio J A, Dy M, Murray L, Burdick M D, Xue Y Y, Strieter R M, Keane M P. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis. J Immunol 2004; 173: 4692–4698
   PubMed Web of Science ®Google Scholar
• Klosner G, Trautinger F, Knobler R, Neuner P. Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a TH1 to a TH2 response. J Invest Dermatol 2001; 116: 459–462
   PubMed Web of Science ®Google Scholar
• Izbicki G, Segel M J, Christensen T G, Conner M W, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 2002; 83: 111–119
   PubMed Web of Science ®Google Scholar
• Kremer S, Breuer R, Lossos I S, Berkman N, Christensen T G, Connor M W, Goldstein R H, Or R. Effect of immunomodulators on bleomycin-induced lung injury. Respiration 1999; 66: 455–462
   PubMed Web of Science ®Google Scholar
• Ashcroft T, Simpson J M, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41: 467–470
   PubMed Web of Science ®Google Scholar
• Wynn T A. Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol. 2004; 4: 583–594
   PubMed Web of Science ®Google Scholar
• Haider Y, Malizia A P, Keating D T, Birch M, Tomlinson A, Martin G, Ferguson M W, Doran P P, Egan J J. Host predisposition by endogenous transforming growth factor-beta1 overexpression promotes pulmonary fibrosis following bleomycin injury. J Inflamm 2007; 4: 18–31
   Google Scholar
• Weaver C T, Harrington L E, Mangan P R, Gavrieli M, Murphy K M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677–688
   PubMed Web of Science ®Google Scholar
• Li M O, Flavell R A. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008; 28: 468–476
   PubMed Web of Science ®Google Scholar
• Rubtsov Y P, Rasmussen J P, Chi E Y, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson W R, Jr, Muller W, Rudensky A Y. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28: 546–558
   PubMed Web of Science ®Google Scholar
• Di Renzo M, Sbano P, De Aloe G, Pasqui A L, Rubegni P, Ghezzi A, Auteri A, Fimiani M. Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin Exp Immunol 2008; 151: 407–413
   PubMed Web of Science ®Google Scholar
• Garantziotis S, Brass D M, Savov J, Hollingsworth J W, McElvania-TeKippe E, Berman K, Walker J K, Schwartz D A. Leukocyte-derived IL-10 reduces subepithelial fibrosis associated with chronically inhaled endotoxin. Am J Respir Cell Mol Biol 2006; 35: 662–667
   PubMed Web of Science ®Google Scholar
• Barr M L, Meiser B M, Eisen H J, Roberts R F, Livi U, Dall'Amico R, Dorent R, Rogers J G, Radovanceviæ B, Taylor D O, Jeevanandam V, Marboe C C. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998; 339: 1744–1751
   PubMed Web of Science ®Google Scholar